MTA1 and colorectal carcinoma: Therefore, re-expression of KRAS, MTA1 or HMGA2 reverses the miR-543-induced inhibition of the proliferation, migration and invasion of CRC cells in vitro, indicating that KRAS, MTA1 and HMGA2 are functional targets of miR-543 in CRC cells.